Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Acasti Pharma Inc. ACST

Set alert

Price alert · ACST

All alert types
3.37 +3.37 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
34.17M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-2.67
Beta
1.52
Short ratio
3.84
Inst. own
21.23%
Dividend
0.00
Ex-div date
Earnings
Nov 11, 2024
50-d avg
3.05
200-d avg
2.99
1y target
7.97

MAX chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The all-time price history for ACST has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

8.51 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -7.0×
FY 2017: -1.9×FY 2018: -9.0×FY 2019: -10.2×FY 2020: -2.2×FY 2021: -3.6×FY 2022: -4.6×FY 2023: -0.5×FY 2024: -2.6×FY 2025: -4.2×FY 2026: -7.0×
FY 2017 5y median -4.2× FY 2026
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 363×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
P/B 0.8×
FY 2017: 0.9×FY 2018: 18.6×FY 2019: 30.3×FY 2020: 4.3×FY 2021: 1.3×FY 2022: 0.4×FY 2023: 0.3×FY 2024: 0.5×FY 2025: 0.6×FY 2026: 0.8×
FY 2017 5y median 0.5× FY 2026
P/FCF -6.1×
FY 2017: -2.3×FY 2018: -15.2×FY 2019: -18.0×FY 2020: -2.4×FY 2021: -4.9×FY 2022: -2.6×FY 2023: -1.3×FY 2024: -2.7×FY 2025: -2.7×FY 2026: -6.1×
FY 2017 5y median -2.7× FY 2026
EV/EBITDA 5311×
FY 2017: -1.5×FY 2018: -8.3×FY 2019: -12.1×FY 2020: -1.2×FY 2021: -2.1×FY 2022: -1.2×FY 2023: 2.8×FY 2024: -0.7×FY 2025: 2502×FY 2026: 5311×
FY 2017 5y median 2.8× FY 2026
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 104×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
FCF Yield -16.4%
FY 2017: -43.6%FY 2018: -6.6%FY 2019: -5.5%FY 2020: -42.0%FY 2021: -20.2%FY 2022: -38.3%FY 2023: -77.6%FY 2024: -37.6%FY 2025: -37.6%FY 2026: -16.4%
FY 2017 5y median -37.6% FY 2026

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 61.2%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -8377.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -10039.8%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
ROE -14.9%
FY 2017: -48.6%FY 2018: -206.0%FY 2019: -297.2%FY 2020: -196.3%FY 2021: -35.4%FY 2022: -9.1%FY 2023: -62.4%FY 2024: -20.8%FY 2025: -19.2%FY 2026: -14.9%
FY 2017 5y median -19.2% FY 2026
ROIC 0.0%
FY 2017: -44.0%FY 2018: -93.8%FY 2019: -102.6%FY 2020: -157.4%FY 2021: -26.8%FY 2022: -11.3%FY 2023: -74.4%FY 2024: -29.1%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median -11.3% FY 2026
ROA -14.2%
FY 2017: -41.5%FY 2018: -73.8%FY 2019: -89.0%FY 2020: -111.6%FY 2021: -31.5%FY 2022: -7.6%FY 2023: -53.6%FY 2024: -17.5%FY 2025: -17.7%FY 2026: -14.2%
FY 2017 5y median -17.5% FY 2026

Growth (YoY)

Revenue 0.0%
FY 2017: -100.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -100.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 FY 2026
Operating Income 0.0%
FY 2017: -11.6%FY 2018: -47.4%FY 2019: -121.0%FY 2020: 26.6%FY 2021: 33.7%FY 2022: 3.1%FY 2023: -334.0%FY 2024: 65.7%FY 2025: 100.0%FY 2026: 0.0%
FY 2017 FY 2026
EPS (diluted) 40.5%
FY 2017: -117.6%FY 2018: 83.0%FY 2019: 16.6%FY 2020: -31.3%FY 2021: 6.1%FY 2022: 79.9%FY 2023: -256.9%FY 2024: 76.4%FY 2025: 41.5%FY 2026: 40.5%
FY 2017 FY 2026
Free Cash Flow 40.5%
FY 2017: -70.9%FY 2018: -14.8%FY 2019: -147.3%FY 2020: 6.4%FY 2021: 38.2%FY 2022: -19.8%FY 2023: 7.6%FY 2024: 22.4%FY 2025: -20.6%FY 2026: 40.5%
FY 2017 FY 2026

Financial Health

Current Ratio 8.1×
FY 2017: 4.8×FY 2018: 1.4×FY 2019: 2.0×FY 2020: 2.2×FY 2021: 39.5×FY 2022: 13.9×FY 2023: 8.6×FY 2024: 14.3×FY 2025: 11.8×FY 2026: 8.1×
FY 2017 5y median 11.8× FY 2026
Quick Ratio 8.1×
FY 2017: 4.8×FY 2018: 1.4×FY 2019: 2.0×FY 2020: 2.2×FY 2021: 39.5×FY 2022: 13.9×FY 2023: 8.6×FY 2024: 14.3×FY 2025: 11.8×FY 2026: 8.1×
FY 2017 5y median 11.8× FY 2026
Debt / Equity 0.0×
FY 2017: 0.1×FY 2018: 0.2×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA -2425×
FY 2017: 1.0×FY 2018: 0.4×FY 2019: 0.6×FY 2020: 0.4×FY 2021: 5.2×FY 2022: 2.5×FY 2023: 11.3×FY 2024: 1.6×FY 2025: -3162×FY 2026: -2425×
FY 2017 5y median 1.6× FY 2026
Interest Coverage 0.0×
FY 2017: -190×FY 2018: -53.8×FY 2019: -123×FY 2020: -100×FY 2021: -62.2×FY 2022: -71.1×FY 2023: -1.0×FY 2024: -26.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median -1.0× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-03-31